Edition:
United States

Celsion Corp (CLSN.OQ)

CLSN.OQ on NASDAQ Stock Exchange Capital Market

2.77USD
13 Aug 2018
Change (% chg)

-- (--)
Prev Close
$2.77
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
29,818
52-wk High
$6.06
52-wk Low
$1.25

Select another date:

Mon, Apr 9 2018

BRIEF-Celsion Phase III Clinical Study Of Thermodox In Combination With Radiofrequency Ablation To Continue According To Protocol

* PHASE III CLINICAL STUDY OF THERMODOX IN COMBINATION WITH RADIOFREQUENCY ABLATION TO CONTINUE ACCORDING TO PROTOCOL Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Select another date: